For Immediate Release

Contact: David Reinbold, dreinbold@americanhumanist.org

(June 13, 2024, Washington, D.C.) — Today the Supreme Court ruled unanimously that the anti-abortion group that brought a challenge to Mifepristone, a common abortion drug, did not have standing to bring this case. The American Humanist Association is pleased with this decision and is proud to have been a part of an amicus brief in support of the Federal Drug Administration and the accessibility of Mifepristone.

While we are relieved that the Supreme Court did not strike down access to this important prescription medicine today, we are clear that this fight is far from over. Since the Supreme Court struck down Roe v. Wade, Congress has still failed to replace those protections, throwing patients and providers into a chaotic legal landscape that makes it almost certain that additional challenges to this safe and effective drug will continue to be brought forward by Christian nationalists.

“While today we feel relief, we know that the fight for abortion access is far from over. The AHA calls on Congress and the Administration to act by swiftly passing the Women’s Health Protection Act and the Abortion Justice Act to codify strong protections for abortion access and reproductive justice across the nation,” said Lily Bolourian, AHA’s Legal and Policy Director.

###

The American Humanist Association (AHA) works to protect the rights of humanists, atheists, and other nontheistic Americans. The AHA advances the ethical and life-affirming worldview of humanism, which—without beliefs in gods or other supernatural forces—encourages individuals to live informed and meaningful lives that aspire to the greater good of humanity.